Unitat de Farmacologia i Farmacognòsia, Facultat de Farmàcia, Nucli Universitari de Pedralbes, Universitat de Barcelona, Institut de Biomedicina de la UB (IBUB), Av. Joan XXIII s/n, 08028 Barcelona, Spain.
Toxicol Appl Pharmacol. 2010 May 1;244(3):344-53. doi: 10.1016/j.taap.2010.01.014. Epub 2010 Feb 2.
Previous work by our group demonstrated that homomeric alpha7 nicotinic acetylcholine receptors (nAChR) play a role in the neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA), as well as the binding affinity of this drug to these receptors. Here we studied the effect of MDMA on the activation of nAChR subtypes, the consequent calcium mobilization, and calpain/caspase 3 activation because prolonged Ca(2+) increase could contribute to cytotoxicity. As techniques, we used fluorimetry in Fluo-4-loaded PC12 cells and electrophysiology in Xenopus oocytes. MDMA produced a rapid and sustained increase in calcium without reaching the maximum effect induced by ACh. It also concentration-dependently inhibited the response induced by ACh, nicotine, and the specific alpha7 agonist PNU 282987 with IC(50) values in the low micromolar range. Similarly, MDMA induced inward currents in Xenopus oocytes transfected with human alpha7 but not with alpha4beta2 nAChR and inhibited ACh-induced currents in both receptors in a concentration-dependent manner. The calcium response was inhibited by methyllycaconitine (MLA) and alpha-bungarotoxin but not by dihydro-beta-erythroidine. These results therefore indicate that MDMA acts as a partial agonist on alpha7 nAChRs and as an antagonist on the heteromeric subtypes. Subsequently, calcium-induced Ca(2+) release from the endoplasmic reticulum and entry through voltage-operated calcium channels are also implicated as proved using specific antagonists. In addition, treatment with MDMA for 24 h significantly increased basal Ca(2+) levels and induced an increase in alpha-spectrin breakdown products, which indicates that calpain and caspase 3 were activated. These effects were inhibited by pretreatment with MLA. Moreover, pretreatment with MDMA induced functional upregulation of calcium responses to specific agonists of both heteromeric and alpha7 nAChR. Sustained calcium entry and calpain activation could favor the activation of Ca(2+)-dependent enzymes such as protein kinase C and nitric oxide synthase, which are involved in the generation of ROS and the blockade of the dopamine transporter. This, together with caspase 3 activation, must play a role in MDMA-induced cytotoxicity.
先前我们的研究小组已经证明,同型烟碱型乙酰胆碱受体(nAChR)在 3,4-亚甲二氧基甲基苯丙胺(MDMA)诱导的神经毒性以及该药物与这些受体的结合亲和力中发挥作用。在这里,我们研究了 MDMA 对 nAChR 亚型激活、随后的钙动员以及钙蛋白酶/半胱天冬酶 3 激活的影响,因为延长的 Ca(2+)增加可能导致细胞毒性。我们使用 Fluo-4 加载的 PC12 细胞中的荧光法和 Xenopus 卵母细胞中的电生理学技术。MDMA 迅速且持续地增加钙,但未达到 ACh 诱导的最大效果。它还浓度依赖性地抑制 ACh、尼古丁和特定的 alpha7 激动剂 PNU 282987 诱导的反应,IC(50) 值处于低微摩尔范围内。同样,MDMA 诱导转染人 alpha7 的 Xenopus 卵母细胞中的内向电流,而不是 alpha4beta2 nAChR,并且以浓度依赖性方式抑制两种受体的 ACh 诱导电流。钙反应被甲基lycaconitine (MLA) 和 alpha-bungarotoxin 抑制,但不受二氢-beta-erythroidine 抑制。因此,这些结果表明 MDMA 作为 alpha7 nAChR 的部分激动剂和异源二聚体的拮抗剂起作用。随后,通过使用特定的拮抗剂证实,钙诱导的内质网 Ca(2+) 释放和通过电压门控钙通道的进入也涉及其中。此外,用 MDMA 处理 24 小时显著增加基础 Ca(2+) 水平并诱导 alpha- spectrin 断裂产物增加,这表明钙蛋白酶和半胱天冬酶 3 被激活。这些作用被 MLA 的预处理抑制。此外,MDMA 的预处理诱导钙对异源二聚体和 alpha7 nAChR 的特定激动剂的反应的功能上调。持续的钙进入和钙蛋白酶激活可能有利于钙依赖性酶(如蛋白激酶 C 和一氧化氮合酶)的激活,这些酶参与 ROS 的产生和多巴胺转运体的阻断。这与半胱天冬酶 3 的激活一起,在 MDMA 诱导的细胞毒性中必须发挥作用。